BCYC Q4 2020 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-27.1% YoY

Gross Profit

-$6M-161.4% margin

Operating Income

-$17M-443.3% margin

Net Income

-$17M-453.0% margin

EPS (Diluted)

$-0.83

QoQ Revenue Growth

+0.2%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$161M

Total Liabilities

$66M

Stockholders' Equity

$95M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$5M	-27.1%
Gross Profit	-$6M	-$1M	-353.9%
Operating Income	-$17M	-$5M	-258.1%
Net Income	-$17M	-$4M	-295.7%